NTU Theses and Dissertations Repository: 醫學檢驗暨生物技術學系

醫學檢驗暨生物技術學系 : [467] Collection home page

Browse

Collection's Items (Sorted by Title in Ascending order): 321 to 340 of 467

Publication Year	Title	Author(s)	Department
2016	探討新穎抗金黃色葡萄球菌藥物SC-5005的作用機制 Investigate the mechanism of action of a Novel Anti-Staphylococcal Agent, SC-5005	Sheng-Hsuan Huang; 黃笙軒	醫學檢驗暨生物技術學研究所
2015	探討新穎的抗金黃色葡萄球菌藥物SC-5005 Investigation of a Novel Antibacterial Agent SC-5005 against Staphylococcus aureus	Han-Chu Chang; 張翰築	醫學檢驗暨生物技術學研究所
2021	探討游離型Hepsin對前列腺癌細胞在小鼠肺臟的影響 The Effect of Soluble Hepsin on Prostate Cancer Cells in The Lungs of Mice	Chen-Hsiang Yang; 楊振翔	醫學檢驗暨生物技術學研究所
2024	探討熱休克蛋白 DNAJB4/HLJ1 和熱休克因子 HSF1 調控機制在脂肪組織生成過程中所扮演之角色 Investigating the Regulatory Mechanism between Heat Shock Protein 40 (DNAJB4) and Heat Shock Factor 1 (HSF1) in White Adipose Tissue Biogenesis	林俊宏; Kevin Devlin	醫學檢驗暨生物技術學系
2024	探討熱休克蛋白Dnajb4/HLJ1在調節乙醯胺酚引發肝損傷的作用 Investigation of heat shock protein, Dnajb4/HLJ1, in modulating acetaminophen-induced liver injury	陸致云; Chih-Yun Lu	醫學檢驗暨生物技術學系
2021	探討突變型EGFR透過粒線體代謝轉變促進腫瘤生成 Study of Activating Mutant EGFR Driven Tumor Initiation through Mitochondria-Mediated Metabolism Shift	Cheng-Fang Wu; 吳承芳	醫學檢驗暨生物技術學研究所
2009	探討突變型人類凝血第九因子的功能 Functional Characterization of Mutant Human Coagulation factor IX	Chia-Ni Lin; 林佳霓	醫學檢驗暨生物技術學研究所
2022	探討第二型人類表皮生長因子受體陽性癌症之抗藥性機制 Investigating resistance mechanisms to anti-HER2 therapy for HER2-positive cancers	Yu-Wen Huang; 黃鈺雯	醫學檢驗暨生物技術學研究所
2016	探討第二型穿膜絲胺酸蛋白酶中之Hepsin對第一型干擾素表現之調控 The Effect of Hepsin in Type I Interferon Induction Pathways	Fu Hsin; 幸芙	醫學檢驗暨生物技術學研究所
2018	探討粒線體之型態在c-Met誘發之抗藥性肺癌細胞株中的變化 Mitochondria Morphological Change in c-Met Mediated Drug Resistant Lung Cancer Cells	Ching Li; 李晴	醫學檢驗暨生物技術學研究所
2017	探討精子特異性蛋白質SMZ-1及SMZ-2調節線蟲成精作用 Spermatogenic-specific proteins SMZ-1 and SMZ-2 regulate spermatogenesis in the nematode Caenorhabditis elegans	Hsiao-Fang Peng; 彭筱芳	醫學檢驗暨生物技術學研究所
2016	探討肺癌中巨噬細胞影響的癌症進程及SPANXA抑制腫瘤轉移的機制 Mechanisms of Tumor Associated Macrophage-altered Cancer Progression and SPANXA-mediated Metastatic Suppression in Lung Cancer	Yi-Jing Hsiao; 蕭乂菁	醫學檢驗暨生物技術學研究所
2024	探討脂聯素受體促效劑AdipoRon 引起乳癌細胞株鐵依賴性死亡之機制 Investigating the mechanism of adiponectin receptor agonist, AdipoRon-induced ferroptosis in breast cancer cell lines	賈子怡; Tzu-Yi Chia	醫學檢驗暨生物技術學系
2007	探討脂蛋白元AV基因單一核苷酸多型性與HIV患者接受蛋白酶抑制劑治療後血漿中高三酸甘油酯濃度之相關性 Determination of the association between particular APOA5 SNPs and elevated plasma TG level after protease inhibitor treatment in HIV patients	Wei-Shin Ko; 柯惟信	醫學檢驗暨生物技術學研究所
2020	探討致病性長鏈非編碼核糖核酸IRAK3-3與VP1特異性擴增的T細胞受體庫在71型腸病毒感染中之影響 Characterization of pathogenic lncIRAK3-3 and expanded VP1-specific TCR clones on EV71 pathogenesis	Yu-Wen Liao; 廖郁紋	醫學檢驗暨生物技術學研究所
2011	探討致癌基因MALL在非小細胞肺癌中扮演的角色 The Oncogenic Role of MALL in NSCLC	Yen Chun-Lai; 賴彥君	醫學檢驗暨生物技術學研究所
2023	探討藉由誘發鐵死亡增加Molm13-XR和MV4-11-XR血癌細胞株對於cabozantinib之敏感性的可行性 Exploration of the feasibility of increasing sensitivity to cabozantinib by inducing ferroptosis in Molm13-XR and MV4-11-XR leukemia cell lines	張簡芝芳; Chih-Fang Chang Chien	醫學檢驗暨生物技術學系
2007	探討趨化素受體在頭頸癌中表現與調控機制 Regulation of chemokine receptor expression profiles in head and neck cancer	Da-Liang Ou; 歐大諒	醫學檢驗暨生物技術學研究所
2010	探討過敏性紫斑症之Th1與Th17 cells之角色及建立小鼠動物模式 The Role of Th1/Th17 Cells and Establishment of Mouse Model in Henoch-Schonlein Purpura	Hsiao-Yu Jen; 任曉玉	醫學檢驗暨生物技術學研究所
2015	探討選擇性抑制劑cabozantinib在in vitro及in vivo 針對帶有 FLT3-ITD突變之難治型急性骨髓性白血病的抑殺效果 Exploration of cabozantinib as selective inhibitor against refractory acute myeloid leukemia with FLT3-ITD mutations in vitro and in vivo	Heng-An Liao; 廖珩安	醫學檢驗暨生物技術學研究所

Collection's Items (Sorted by Title in Ascending order): 321 to 340 of 467

< previous next >

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

醫學檢驗暨生物技術學系 : [467] Collection home page

Discover